When was Optra SCAN founded?

Optra SCAN was founded in 2012 and raised its 1st funding round 12 years after it was founded.

Where is Optra SCAN located?

Optra SCAN is headquartered in Sunnyvale, United States. It is registered at Office no. 401, 4th Floor ,Pramila Laxman Complex Sadhu Vaswani Road, Pune, Pune, Maharashtra, India, 411001.

Who is the current CEO of Optra SCAN?

Gauri Naik of Optra SCAN. They have also founded 1 company.

Which legal entities is Optra SCAN associated with?

Optra SCAN is associated with OPTRASCAN INDIA PRIVATE LIMITED.

How many employees does Optra SCAN have?

As of Jul 31, 2026, the latest employee count at Optra SCAN is 65.

Is Optra SCAN a funded company?

Optra SCAN is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Nov 15, 2024.

When was the latest funding round of Optra SCAN?

Optra SCAN's latest funding was a $***** Series B round on Nov 15, 2024, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

What is the annual revenue of Optra SCAN?

Annual revenue of Optra SCAN is less than ₹10 Cr as on Mar 31, 2025

Where does Optra SCAN rank among its competitors?

Optra SCAN ranks 4th amongst 25 active competitors, of which 8 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was AlleSense, which secured $1.79M in May, 2026.

Who are the top competitors of Optra SCAN?

Optra SCAN's top competitors include Morphle, Grundium and Akoya Biosciences. Among them, AlleSense secured the most recent funding round in May, 2026.

Optra SCAN - 2026 Company Profile, Team, Funding, Competitors & Financials

Optra SCAN is a series B company based in Sunnyvale (United States), founded in 2012 by Gauri Naik. It operates as a Digital pathology solutions for smarter, faster diagnostics and improved patient outcomes. Optra SCAN has raised $30M in funding from Molbio Diagnostics. The company has 25 active competitors, including 8 funded and 2 that have exited. Its top competitors include companies like Morphle, Grundium and Akoya Biosciences.

Company Details

Digital pathology solutions for smarter, faster diagnostics and improved patient outcomes. The company pioneers advanced digital slide scanners and AI-driven solutions, transforming pathology services. They empower healthcare institutions to transition to digital pathology, enhancing diagnostics, research, and education. Their technology offers high-speed imaging and analysis, streamlining lab workflows and improving patient outcomes. They provide whole slide scanners, AI-based analytics for automated abnormality detection, telepathology for remote consultations, and e-learning platforms for pathology education. Image management software ensures secure storage and analysis. Their solutions are cloud-based, HIPAA-compliant, and offer seamless integration. They provide flexible, scalable, and high-performance pathology solutions, improving diagnostic speed, accuracy, and collaboration.

Website: www.optrascan.com/
Part Of
Registered Address: Office no. 401, 4th Floor ,Pramila Laxman Complex Sadhu Vaswani Road, Pune, Pune, Maharashtra, India, 411001

Key Metrics

Founded Year

2012

Location

Sunnyvale, United States

Stage

Series B

Total Funding

$30M in 1 round

Latest Funding Round

Series B, Nov 15, 2024, $*****

Investors

Molbio Diagnostics & 1 more

Ranked

4^th among 25 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

65 as on Jul 31, 2026

Similar Companies

Morphle & 23 more

View Optra SCAN's full profile

Optra SCAN is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OPTRASCAN INDIA PRIVATE LIMITED CIN: U33205PN2018FTC177161 , India, Active	Jun 12, 2018	0 - ₹10 Cr (As on Mar 31, 2025)	42 (As on Aug 31, 2025)

Optra SCAN has raised a total funding of $30M over 1 round. Its latest funding round was a Series B round on Nov 15, 2024 for $*****. 1 investor participated in its latest round. Optra SCAN has 2 institutional investors.

Here is the list of recent funding rounds of Optra SCAN:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 15, 2024	5919413	Series B	7056003	9576643	4124149	9270459

Access funding benchmarks and valuations. Sign up today!

View details of Optra SCAN's funding rounds and investors

The founders of Optra SCAN is Gauri Naik. Gauri Naik is the CEO of Optra SCAN.

Here are the details of Optra SCAN's key team members:

Gauri Naik: Co-Founder & Co-CEO of Optra SCAN.
Contact Info: 1 email address

View details of Optra SCAN's Founder profiles and Board Members

Optra SCAN's employee count trend

Optra SCAN has 65 employees as of Jul 26. Here is Optra SCAN's employee count trend over the years:

Uncover Optra SCAN's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Optra SCAN include Morphle, Grundium and Akoya Biosciences. Here is the list of Top 10 competitors of Optra SCAN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Morphle 2017, Bengaluru (India), Series A	Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.	$5.15M	Inflexor, Y Combinator & 4 others	61/100
2nd	Grundium 2015, Tampere (Finland), Acquired	Provides portable scanning microscope for medical researcher	$2.37M	Ascend Capital Partners, EIC Fund & 1 others	56/100
3rd	Akoya Biosciences 2015, San Francisco (United States), Acquired	Provider of solutions for rapid proteomic profiling	$83.5M	Piper Jaffray, HTIF & 4 others	55/100
4th	Optra SCAN 2012, Sunnyvale (United States), Series B	Digital pathology solutions for smarter, faster diagnostics and improved patient outcomes	$30M	Optra Ventures, Molbio Diagnostics	49/100
5th	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	OTV, OurCrowd & 15 others	46/100
6th	PreciPoint 2018, Freising (Germany), Series A	Developer of digital microscopes and micro-positioning systems	$10.2M	Neue Fund, Harmonix & 11 others	41/100
7th	AlleSense 2020, Melbourne (Australia), Seed	Provider of microscopic slides for imaging purposes	$3.49M	Breakthrough Victoria	35/100
8th	Livo 2018, Hyderabad (India), Seed	Manufacturer of next-generation pathology laboratory equipment	$746K	Hyderabad Angels & 6 others	34/100
9th	Macula Vision Systems 2022, Tucson (United States), Seed	Developer of automated computational microscopy solutions for clinical laboratories	-	Brooks Hill Partners, National Science Foundation	29/100
10th	Motic Digital Pathology 2019, United States, Unfunded	Digital pathology solutions for accessible, collaborative, and efficient healthcare	-	-	27/100